Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ewopharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2788
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers market evaluation services such as market analysis, evaluating sales potential, conducting feasibility studies, establishing business plans, identifying cooperation and licensing opportunities, reporting on market conditions, and others. Ewopharma offers regulatory affairs services such as preparing health registration submissions, completing and translating documentation and organizing and monitoring clinical studies, among others. The company has operations in Bulgaria, Croatia, Estonia, Hungary, Poland, the Czech Republic, Slovakia, Romania and Slovenia, among others. Ewopharma is headquartered in Schaffhausen, Switzerland.

Ewopharma AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ewopharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ewopharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ewopharma AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ewopharma and Eisai Enter into Co-Marketing Agreement 10
Ewopharma Enters into Distribution Agreement with Biogen 11
Licensing Agreements 12
Ewopharma Enters into Licensing Agreement with Shield Therapeutics 12
Ewopharma AG – Key Competitors 13
Ewopharma AG – Key Employees 14
Ewopharma AG – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Ewopharma AG, Pharmaceuticals & Healthcare, Key Facts 2
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ewopharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ewopharma AG, Deals By Therapy Area, 2012 to YTD 2018 8
Ewopharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ewopharma and Eisai Enter into Co-Marketing Agreement 10
Ewopharma Enters into Distribution Agreement with Biogen 11
Ewopharma Enters into Licensing Agreement with Shield Therapeutics 12
Ewopharma AG, Key Competitors 13
Ewopharma AG, Key Employees 14
Ewopharma AG, Other Locations 15
Ewopharma AG, Subsidiaries 16

List of Figures
Ewopharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ewopharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ewopharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adynxx Inc (ADYX):企業の財務・戦略的SWOT分析
    Summary Adynxx Inc (Adynxx), formerly known as Alliqua BioMedical, Inc, is a clinical stage biopharmaceutical company. It utilizes AYX transcription factor decoys to create therapies with disease changing properties. The company is involved in the development of transcription factor decoy technology …
  • Turner Broadcasting System Inc:企業の戦略的SWOT分析
    Turner Broadcasting System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Enzymotec Ltd:企業の戦略・SWOT・財務情報
    Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report Summary Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Central Bank of the Russian Federation:企業の戦略的SWOT分析
    The Central Bank of the Russian Federation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …
  • C3J Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary C3J Therapeutics Inc (C3J), formerly C3 Jian Inc, is a clinical-stage biotechnology company which concentrates on the development and commercialization of targeted and pathogen specific, antimicrobials that treat and prevent diseases caused by microbial dysbiosis. Its pipeline product portfo …
  • Access Bio Inc (950130):企業の製品パイプライン分析2018
    Summary Access Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. …
  • Emsland Group:企業の戦略・SWOT・財務情報
    Emsland Group - Strategy, SWOT and Corporate Finance Report Summary Emsland Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ascendance Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • Xiwang Sugar Holdings Co Limited:企業の戦略・SWOT・財務情報
    Xiwang Sugar Holdings Co Limited - Strategy, SWOT and Corporate Finance Report Summary Xiwang Sugar Holdings Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • SomaLogic Inc:企業の製品パイプライン分析2018
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Centene Corp (CNC)-製薬・医療分野:企業M&A・提携分析
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Coherex Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Coherex Medical Inc (Coherex), formerly Proximare, Inc is a subsidiary of Johnson & Johnson is a medical device company that designs, develops and markets catheter-based technologies for the treatment of certain structural heart defects. The company provides treatment of cardiovascular disea …
  • Corvia Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Corvia Medical Inc (Corvia), formerly DC Devices Inc, is a medical device company that offers treatment of heart failure with structural heart devices. The company’s interatrial shunt device (IASD), a trans-catheter device and non-surgical medical device, is designed to treat diastolic heart …
  • Flowserve Corporation:企業の戦略・SWOT・財務情報
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Emzor Pharmaceutical Industries Ltd:企業の戦略的SWOT分析
    Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Alabama Municipal Electric Authority:企業の発電所・SWOT分析2018
    Alabama Municipal Electric Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Begbies Traynor Group plc (BEG):企業の財務・戦略的SWOT分析
    Summary Begbies Traynor Group plc (BTG) is a business and consultancy service provider. The company offers professional services such as business rescue options, advisory options, forensic accounting and investigations, corporate and commercial finance, personal insolvency solutions and services. It …
  • CWC Energy Services Corp (CWC):石油・ガス:M&Aディール及び事業提携情報
    Summary CWC Energy Services Corp (CWC), formerly CWC Well Services Corp, is an oilfield servicing company that provides drilling rigs, service rigs, coil tubing and well testing services in the Western Canadian Sedimentary Basin. The company operates through two divisions such as contract drilling a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆